Advertisement · 728 × 90
#
Hashtag
#ASCVD
Advertisement · 728 × 90
Post image

At #ACC26, DCRI’s @nishantshahmd.bsky.social offered up a practical recipe to take GLP-1 agonists from ‘pharm to table’ within any clinic, while still allowing physicians to add their own ‘spice’ to accommodate a patient’s unique needs. #cvMetabolic #ASCVD #CardioSky

0 0 0 0
Post image

🆕 #ACC26 Late-Breaking Trial 👇

Ez-PAVE: Lowering LDL-C to <55 mg/dL in patients with #ASCVD reduced the rate of major cardiovascular events by one-third.

Want the full results? Keep reading ➡️ https://bit.ly/414OLeG #cvPrev

0 2 0 0
Post image

Elevated Lp(a) doesn't just raise #CV risk, it carries a major economic price tag. Data shared by @nishantshahmd.bsky.social at #ACC26 shows the highest Lp(a) group incurs $506/person/year or $253M over 5 years, in indirect costs. The case for early testing is clear. #ASCVD #cvLipids #CardioSky

0 0 0 0
Video

Join Ty Gluckman, MD, and colleagues for a case-based Master Class focused on closing gaps in ASCVD prevention — from Lp(a) testing to personalized lipid-lowering strategies.

Practical insights you can apply in clinic. Register: https://bit.ly/4aBDE1d

#Cardiology #ASCVD #MedicalEducation

0 0 0 0
Post image

Prevention is about clear communication and action, not just knowledge.

📖 Read more: https://ow.ly/uWZc50YxAXg

#Cardiology #PreventiveCardiology #HealthCommunication #ASCVD #CardioSky #MedSky

0 1 0 1
Preview
Association Between Ultraprocessed Food Consumption and Cardiovascular Disease Risk: MESA (Multiethnic Study of Atherosclerosis)

Consumo elevado de alimentos ultraprocesados se asocia con un riesgo elevado de eventos CV ateroscleróticos, siendo mayor el riesgo en los negros #UPF #ASCVD www.jacc.org/doi/10.1016/...

0 0 0 0
Post image

Higher consumption of ultraprocessed foods was significantly associated w/ an ↗️ risk for #ASCVD events, w/ a more pronounced association among Black Americans, based on findings from the MESA being presented at #ACC26.

Read more: https://bit.ly/4bBxAX2 #CardioSky #MedSky #JACCAdvances

1 2 0 0
Post image

The 2026 ACC/AHA Multisociety #Dyslipidemia Guideline-at-a-Glance offers a visual summary of key updates in CV risk assessment, lipid treatment goals, & #ASCVD risk reduction.

A quick reference for clinicians: https://bit.ly/4rGIMHY

#JACC #ClinicalGuidelines #cvLipids #CardioSky

1 2 0 0
Preview
Childhood oral health is associated with the incidence of atherosclerotic cardiovascular disease in adulthood While adult oral health has been consistently linked to cardiovascular disease, the long-term impact of childhood oral health remains underexplored. Thus, we investigated the association between denta...

Mala salud oral infantil, particularmente la caries dental persistente o empeorando, se asocia con un riesgo elevado de enfermedad CV aterosclerótica en la edad adulta #oralhealth #ASCVD www.internationaljournalofcardiology.com/article/S016...

0 0 0 0
Post image

ACC/AHA & 9 other leading medical associations released an updated clinical guideline for managing #dyslipidemia. About 1 in 4 US adults has high LDL-C, raising risk of heart attack & stroke.

Get the details in #JACC: https://bit.ly/4cLB0J0

#ClinicalGuidelines #cvLipids #ASCVD #CardioSky

6 3 0 0
Preview
Recent advances in research and care of familial hypercholesterolaemia Heterozygous familial hypercholesterolaemia is a common, autosomal semi-dominant condition characterised by elevation of LDL cholesterol from birth and early onset of atherosclerotic cardiovascular di...

Despite advances, #familial #hypercholesterolaemia is still inadequately diagnosed and undertreated, with many affected people remaining at high risk of early #cardiovascular disease www.thelancet.com/journals/lan...
#HeFH #HoFH #ASCVD

#MedSky #EndoSKY #CardioSky

3 2 0 0
Post image

New complimentary #CME!
Get a quick, practical update on LDL-C management in high-risk #ASCVD, including clinical data on new and emerging PCSK9 inhibitors (injectable & oral).

Earn 0.5 CME in 30 minutes.
clinical.med-iq.com/activity/ldl...

#CardioTwitter #MedEd #PCSK9

0 0 0 0
Post image

1/24 In this #CME #MedX, Dr. Blaha explores the evolving landscape of LDL-C management in high-risk patients with #ASCVD, with a focus on the role of PCSK9 inhibitors and a look at emerging novel PCSK9 inhibitor formulations.
Produced w/ @accintouch.bsky.social
Get credit: link.med-iq.com/Xc4w8B

0 0 1 0
Preview
Recent advances in research and care of familial hypercholesterolaemia Heterozygous familial hypercholesterolaemia is a common, autosomal semi-dominant condition characterised by elevation of LDL cholesterol from birth and early onset of atherosclerotic cardiovascular di...

With major advances in knowledge about the disease, #familial #hypercholesterolaemia has become an exemplar for the practice of precision and personalised medicine thelancet.com/journals/lan...
#HoFH #HeFH #ASCVD

#MedSky #EndoSky #CardioSky

2 1 0 1
Bar graphs show smallest worthwhile difference distributions for atherosclerotic cardiovascular disease risk in the US & Japan. Baseline risks are 2%, 10%, & 20%. X-axis: SWD in absolute risk reduction from baseline. Y-axis: percentage of US/Japanese participants.

Bar graphs show smallest worthwhile difference distributions for atherosclerotic cardiovascular disease risk in the US & Japan. Baseline risks are 2%, 10%, & 20%. X-axis: SWD in absolute risk reduction from baseline. Y-axis: percentage of US/Japanese participants.

Most statin-eligible adults in the US and Japan desire greater absolute risk reduction than current statin efficacy provides before initiating therapy for #ASCVD prevention.

ja.ma/46MbaRa

0 0 0 0
Editorial titled, "Statins for Primary Prevention—The Gap Between Guidelines and Patient Preferences" by Ilana B. Richman et al. Text discusses when to use statins for preventing atherosclerotic cardiovascular disease (ASCVD).

Editorial titled, "Statins for Primary Prevention—The Gap Between Guidelines and Patient Preferences" by Ilana B. Richman et al. Text discusses when to use statins for preventing atherosclerotic cardiovascular disease (ASCVD).

💬 Editorial: Statin guidelines and patient preferences for #ASCVD prevention often misalign, supporting the need for clearer risk communication and shared decision-making in clinical practice.

ja.ma/4rKRFAo

1 1 0 0
Bar graphs show smallest worthwhile difference distributions for atherosclerotic cardiovascular disease risk in the US & Japan. Baseline risks are 2%, 10%, & 20%. X-axis: SWD in absolute risk reduction from baseline. Y-axis: percentage of US/Japanese participants.

Bar graphs show smallest worthwhile difference distributions for atherosclerotic cardiovascular disease risk in the US & Japan. Baseline risks are 2%, 10%, & 20%. X-axis: SWD in absolute risk reduction from baseline. Y-axis: percentage of US/Japanese participants.

Most statin-eligible adults in the US and Japan desire greater absolute risk reduction than current statin efficacy provides before initiating therapy for #ASCVD prevention.

ja.ma/4kDy02Y

2 1 0 0
Preview
Enlicitide substantially lowers LDL-C in people at risk for atherosclerotic CVD events The oral PCSK9 inhibitor enlicitide significantly reduces LDL-cholesterol levels in people with a history of, or risk for, atherosclerotic cardiovascular disease events.

#MedNews - The oral PCSK9 inhibitor #enlicitide significantly reduces LDL-C levels in people with a history of, or risk for, #ASCVD events.

Full story 👉 buff.ly/jS4MBME

#CardioSky

0 0 0 0
Post image

New findings highlight clinician-level variation in lipid management for secondary ASCVD prevention, revealing opportunities to standardize care and improve outcomes.
🔗 https://ow.ly/7swS50Y8VHm

#LipidManagement #ASCVD #PreventiveCardiology #PracticeImprovement #CardioSky #MedSky

0 0 0 0
Post image

What predicts diffuse coronary artery calcium in adults ≥75?
New data from the ARIC study identify clinical predictors of diffuse CAC, offering insight into advanced atherosclerosis phenotypes in older adults.

🔗 https://ow.ly/EV4H50Y6mzu

#CardioEpi #CAC #ASCVD

2 0 0 0
Preview
Inclisiran for children: is it worth it? Familial hypercholesterolaemia is one of the most common inherited metabolic disorders, with heterozygous familial hypercholesterolaemia (HeFH) affecting more than 30 million individuals worldwide, a ...

Lluís Masana & Daiana Ibarretxe comment on:
Inclisiran for children: is it worth it? thelancet.com/journals/lan...
#heterozygous #familial #hypercholesterolaemia #HeFH #ASCVD

#MedSky #EndoSky #CardioSky

1 0 0 0
Post image

P. gingivalis in #Atherosclerotic plaques exacerbates plaque instability by disrupting the FOXO3-HDAC2 axis, driving #OxidativeStress-mediated macrophage #Necroptosis, thus establishing a causative link between periodontal health and #ASCVD.

#OpenAccess: doi.org/10.1038/s413...

2 0 0 0
Post image

The application of implementation science to expanding knowledge of #familial #hypercholesterolaemia has enabled the development and design of potentially more effective models of care thelancet.com/journals/lan...
#HoFH #HeFH #ASCVD

#MedSky #EndoSky #CardioSky

1 0 0 0
Preview
SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide The drug was as good as a proven GLP-1, giving doctors another potent option for patients with type 2 diabetes and atherosclerotic cardiovascular disease.

💊The newly published SURPASS-CVOT trial shows tirzepatide (Mounjaro) is as effective as dulaglutide in reducing major cardiovascular events in patients with type 2 diabetes and #ASCVD, expanding treatment options.

Read more in this TCTMD article➡️ https://ow.ly/izET50XTbeT

#CardioSky

0 0 0 0
Post image

Although heterozygous #familial #hypercholesterolaemia represents one of the most common monogenic conditions in the general population, homozygous familial hypercholesterolaemia is much rarer, occurring in between one in 160 000 & one in 450 000 individuals www.thelancet.com/journals/lan...
#ASCVD

1 0 0 0
Preview
Heart Attack Screening Tools Miss Nearly Half Of At-Risk People, Study Finds - IndiaWest News Heart Attack Screening Tools Miss Nearly Half Of At-Risk People, Study Finds.

Heart Attack Screening Tools Miss Nearly Half Of At-Risk People, Study Finds

Full Story: indiawest.com/heart-attack...

#HeartAttackRisk #HeartHealthStudy #HeartAttackScreening #CardiovascularRisk #SilentHeartDisease #ASCVD #PREVENTScore #MountSinaiStudy #HealthAlert

0 0 0 0
Post image

📣 #Colchicine for the prevention and management of Atherosclerotic #Cardiovascular Disease ⬇️

📌 In this review, van Zelm and colleagues review the evidence for the use of colchicine in #ASCVD

🆓 on TH 👉 www.thieme-connect.de/products/ejo...

#CardioEd #CAD #Cardiology #Cardiosky

1 0 0 0
Preview
Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study Declines in heart failure mortality in both people with and without diabetes were less marked than were declines in CHD and cerebrovascular disease mortality in most jurisdictions. Heart failure morta...

Current efforts to manage #diabetes appear to have narrowed the gap between people with and without diabetes in terms of atherosclerotic CVD mortality, but not in terms of heart failure mortality www.thelancet.com/journals/lan...
#ASCVD #heartfailure

#MedSky #EndoSky #CardioSky

1 2 0 0
Post image

Despite advances, #familial #hypercholesterolaemia remains an underdiagnosed and untreated condition, with an urgent need for the design and implementation of effective models of care www.thelancet.com/journals/lan...
#ASCVD #HeFH #HoFH

#MedSky #EndoSky #CardioSky

1 0 0 0